Organic flow battery firm CMBlu gets €100 million investment

Germany-headquartered organic flow battery company CMBlu has secured €100 million (US$107 million) from technology and construction firm Strabag.

Combining CMBlu’s organic flow battery technology and Strabag’s construction and infrastructure expertise opens up opportunities for industrial companies, utilities and grid operators to build large-scale projects using the tech, the companies said. 

CMBlu’s ‘Organic SolidFlow’ technology is a redox flow battery which uses an electrolyte sourced from organic materials, which it said are cost-effective, environmentally friendly and secure. Most flow battery companies use vanadium as an electrolyte. 

The company has to-date mostly deployed projects in the commercial and industrial (C&I) sector and has received its first orders in the US this year. Last month, it won a 5MW/50MWh order from a utility in Arizona, which followed on from its first order in the market in February

The first commercial project to use its technology at scale was commissioned in July this year, at a wind and solar park in Austria

Dr. Peter Geigle, founder and CEO of CMBlu Energy, commented: “As developers and producers, we can now invest into the construction and expansion of our production facilities. We will especially profit from the broad experience and execution power STRABAG has in large infrastructure projects.”

Klemens Haselsteiner, CEO of Strabag, added: “With our investment in CMBlu Energy, we are breaking new ground in the construction industry. In order to reach one of the most important goals in our company history – becoming climate-neutral by 2040 – we want to become a full-range supplier for energy services for our construction projects. Together, we will deliver large energy storage projects in a standardized construction design – “warehouses for electricity” – even faster, more efficient and easier.”

Flow batteries are one of the more commercial mature alternative technologies to lithium-ion for stationary energy storage, and providers claim that the technology has a lower levelised cost of storage (LCOS) beyond the 4-8-hour duration mark. 

However, lithium-ion continues to be chosen for the largest-scale projects at that duration, partially down to commercial readiness, cost-effectiveness, performance and bankability. 


With a Visit to the Taj Mahal

J Lyons Marketing Signs As An Advisor with India Firm Neuron Group with two founders, Manish Sonar and Pradeep Panwar

Neuron Energy Pvt Ltd pioneers in EV solutions since 2017. Providing cutting-edge new battery technologies for Energy Storage projects in India and beyond.


JOHN LYONS RETURNS FROM GRAPHENE MANUFACTURING GROUP, BRISBANE AUSTRALIA

Met with managing director Craig Nicol to sign for North America Business Development / Marketing Agent


J Lyons Marketing Signs With Neoron Energy 

To bring advanced new battery chemistry to build battery plants  in India for Indian & Australian market coverage 

NEOENRG | NeuronTechlabs |  Neoron Capital Holdings | CERO | Solution Architect | Cloud Architect | 

www.neoenrg.com


J Lyons Marketing Signs With Renmatix 

Renmatix  989 Old Eagle School Rd Suite 805, Wayne, PA 19087

Renmatix is a manufacturer of lignocellulosic materials by way of its patented Plantrose™ process.  Using supercritical water, Renmatix has developed chemical-free methods of extracting high-value, functional materials from commodities and specialised biomass. Omno Bio Base carbon as graphite anode material for LIB, SIB & AIB cell manufacturers 


J Lyons Marketing Signs With Altech From Western Australia

Suite 8, 295 Rokeby Road, Subiaco  Western Australia 6008  

Altech has “cracked the silicon barrier” and successfully produced and tested a series of lithium-ion battery anode materials with ~30% higher retention capacity than conventional lithium-ion battery anode materials.  Altech Batteries Ltd is at the cutting edge of developing battery materials for a Lithium-ion battery future by successfully incorporating silicon in graphite anodes to produce higher energy density batteries. 


Paige Lyons Moves UP!

Excitingly stepping into the role of Account Manager, Paige Lyons brings three years of dedicated service to the company, along with a strategic mindset and a passion for building meaningful client relationships. With exceptional communication skills and a knack for understanding client needs, Paige is poised to drive successful marketing campaigns, contribute to the team's growth, and continue delivering exceptional results.


MedWand has received US FDA 510(k) clearance and is commercially available.

https://medwand.com/faq.html

MedWand

Has MedWand received clearance for clinical use by the FDA or other equivalent organization?
Yes, MedWand has received US FDA 510(k) clearance and is commercially available.

Who would be a typical user of MedWand and the VirtualCare software?
Any healthcare organization wishing to add advanced Virtual Care services to their tele-medicine solution.

What makes MedWand unique compared to other tele-medicine devices?
MedWand is the only available solution that includes multiple clinically accurate vitals sensors that enables clinicians to perform real-time physical exams on their patients over any distance, scheduled by and fully integrated into, existing EHR and patient management systems.

What hardware configurations are available for MedWand?
MedWand Clinics are available in three configurations - Mobile Clinic, Remote Clinic and Office Clinic plus an Evaluation Kit. Each version includes a pre-configured and remotely managed Android OS tablet.

What software is supplied with MedWand?
Each MedWand includes a copy of MedWand VirtualCare software pre-installed on the provided Android OS tablet. The software supports video-based consultations and remote exams from any computer using Google Chrome or Microsoft Edge browsers.

Is MedWand intended to replace my existing tele-medicine software?
MedWand will often be used as a higher capability compliment to existing video conference based telemedicine solutions. Each care organization can choose how to allocate MedWand hardware to those patients within its network that would benefit the most from virtual exams.

What EHR and patient management solutions are compatible with MedWand?
Commonly used EHR and patient management solutions, such as MyChart by Epic and Cerner's Millennium / MHS Genesis, have already been integrated by the MedWand team. Please e-mail info@medwand.com to request the status of your current EHR or practice management system.

What fees are charged to use MedWand services?
A monthly subscription fee is required to use MedWand. This fee provides the user access to the MedWand hardware and pre-configured Android tablet or Windows PC. It also includes no-fault product replacement insurance, and a defined level of access to MedWand VirtualCare services.

Will insurance or other payments cover the cost of MedWand services?
Many commercial insurance plans allow tele-medicine sessions as an allowed expense, and CMS billing codes already exist for applications such as Remote Patient Monitoring. In many use cases significant cost reductions can be gained from operational efficiencies and reduced travel costs.

How do you establish in-field operation with a MedWand?
MedWand connects to a supplied Android tablet or Windows PC via a USB-C cable. With full access to the internet via WiFi, LAN or 4G LTE, MedWand can work anywhere in the world.

Can more than one patient use a single MedWand?
Yes. In applications such as Schools and Care homes, a single nurse will often be responsible for multiple patients. Each patient will typically have an account hosted by the EHR and patient management system which holds all their medical data and insurance information.

What is the patient experience when using a MedWand?
By integrating with existing patient management solutions, most clinician communications with patients remain unchanged. Only those patients or nurses assigned a MedWand Clinic will be aware of the additional hardware and user interface of MedWand's VirtualCare software.

Is MedWand HIPAA compliant?
Yes. All communications and vitals data transmitted over the internet, or temporarily saved in local tablet/PC or Cloud storage are encrypted and anonymized to ensure HIPAA compliance.

What resources does MedWand VirtualCare software run on?
MedWand VirtualCare software is hosted in Oracle Cloud data centers, providing global reach and data sovereignty for customers, combined with 24/7 support and world-class reliability.                             


GREEN DISTILLATION TECHNOLOGIES Corporation Limited Australia

GREEN DISTILLATION TECHNOLOGIES Corporation Limited Signed MOU with Dr. R Mukhopadhyay JK Tyre

memorandum of understanding for proposed project



Sparatech signs MOU with Flite Sciences

announcement


 

GREEN DISTILLATION TECHNOLOGIES Corporation Limited Australia

Winners of 2015 Edison Award for Energy and Sustainability receives Goodyear Letter of Support

Goodyear Letter of Support


image001-2.png
image002-2.jpg
 

4005-A, rue de la Garlock, Sherbrooke (Québec) J1L 1W9 CANADA

The Thymox team is thrilled to share the following news with you : our Thymox Disinfectant Spray (U.S. EPA registration number 87742-1) has been officially recognised as effective against SARS-CoV-2, the virus that causes COVID-19, and so becomes the first disinfectant using a botanically-derived active ingredient to be granted this claim.

Even though the EPA has included Thymox on List N, for disinfectant expected to be effective against SARS-CoV-2, Thymox chose to take the extra step of getting tested against the actual virus that causes COVID-19; this is part of our commitment to continue improving on our products as new tests and standards become available.

thymox disinfectant spray


The 9 top health and medicine breakthroughs of 2020

Popular Science - MedWand / Vetwand
https://www.popsci.com/story/technology/best-health-innovations-2020/

MedWand by MedWand Solutions, Inc.

The next best thing to your doctor

E4NSPTWS6NBC3PRJ4KA2G3PW54.jpeg

Telehealth has long had the potential to transform healthcare for people living in rural areas or those who can’t physically get to the doc, but the COVID-19 pandemic has made it even more critical. MedWand, a clinical-grade diagnostic kit, allows your doctor to gather info that typically requires an in-person visit. About the size of a small coffee mug, the USB-connected setup gives a physician real-time access to data from 10 examination tools, including a stethoscope, an otoscope (for the ears), an ophthalmoscope (for the back of the eyes), and a dermatoscope (for skin lesions)—as well as a thermometer, a pulse oximeter (for monitoring heart rate and blood oxygen levels), and an ECG sensor. The device is pending FDA clearance and should be available once cleared.


NBD Nanotechnologies announces InvisiPrint® MBED™, an anti-fingerprint coating with embedded antimicrobial protection

NBD Nanotechnologies, Inc.

Dec 16, 2020, 08:30 ET

BOSTON, Dec. 16, 2020 /PRNewswire/ -- NBD Nanotechnologies, the surface coating experts, introduced a significant enhancement to their InvisiPrint product by infusing it with MBED; NBD Nano's proprietary antimicrobial material.  MBED antimicrobial is able to keep the InvisiPrint coated surface clean by reducing odor and stain-causing bacteria by 99.9997% (5.7 log) when tested according to ISO 22196.  As it contains an EPA approved active ingredient, applicators can make preservative marketing claims via treated article exemption. InvisiPrint, currently used in the display industries to hide fingerprint smudges, is applied to millions of display screens annually and in June of this year received Frost and Sullivan's New Product Innovation Award for display coatings.

There is a strong need for antimicrobial coatings, especially on displays and touch screens. Display manufacturers are in critical need of implementing solutions that can not only eliminate fingerprint smudges but also reduce the growth of odor or stain causing bacteria.

NBD’s proprietary dual function coating renders fingerprint smudges invisible and prevents the growth of odor and stain-causing bacteria.

InvisiPrint MBED combines best in class fingerprint hiding with exceptional antimicrobial properties. The protection of surfaces with InvisiPrint MBED is also extremely durable.  When surfaces coated with InvisiPrint MBED are exposed to wear and tear similar to what mobile devices and displays typically experience throughout their service life, the 5+ log bacterial reduction is unaffected.  

The low temperature and simple application process combined with excellent fingerprint hiding make InvisiPrint MBED an especially attractive option for high touch electronic displays where anti-fingerprint coatings are already applied but now require antimicrobial properties.  "NBD's ability to introduce innovative product enhancements are the reasons customers continue to depend on NBD Nano for their product roadmap planning and execution. InvisiPrint MBED is yet another example where NBD is successfully providing customers with best-in-class technology," said Miguel Galvez, President of NBD Nanotechnologies.

Applications for InvisiPrint MBED include touch displays, eyewear, appliances, architectural glass, ceramics and other high touch surfaces. For more information, please contact us at info@nbdnano.com

About NBD Nanotechnologies.

Founded in 2012 and based in Lexington Massachusetts, NBD Nanotechnologies, is a rapidly growing specialty chemical company. NBD has a number of tailored coating solutions for the electronics and industrial sectors.

Disclaimers
ISO 22196 results are insufficient to make Health Claims and InvisiPrint® MBED is not registered to make EPA approved Health Claims.

SOURCE NBD Nanotechnologies, Inc.


Northern Ireland Randox LABORATORIES’ John Lamont Senior VP appoints J Lyons Marketing As Their Marketing Agent for North American Market

https://www.randox.com/coronavirus-randox/

Coronavirus Test Available at Randox Laboratories

Randox has developed a rapid test for COVID-19 (SARS-CoV-2), the new strain of coronavirus. Vivalytic  Covid-19 A 45 Minutes POC 100% Automated over 99.9% Accurate ( world’s best )

The game-changing Viral Respiratory Tract Infection (VRI) Array is available on The Vivalytic, a molecular point-of-care platform brought to the market by Randox Laboratories and leading technology manufacturer Bosch Healthcare Solutions. The revolutionary VRI Array can identify SARS-CoV-2 and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses.

randox ad.jpg

Tyrex Resources, LLC signs Letter of Intent with  Green Distillation Technologies Corp, Limited

Letter of interest


IMINT SIGNS A LICENSE DEAL WITH HYSTERA RANK NUMBER TWO GLOBALLY FOR A WEARABLE BODY CAM

https://www.linkedin.com/feed/update/urn:li:activity:6598502230742056960/




Green Distillation Technologies has funding for tire recycling plants in U.S.

ttps://www.rubbernews.com/expansion/green-distillation-technologies-has-funding-tire-recycling-plants-us

WARREN, Australia—Green Distillation Technologies Corp. Ltd., a developer of a "destructive distillation" tire recycling process, claims to have secured a U.S. investor willing to commit up to $100 million for the construction of recycling plants in the U.S. GDT, a Warren-based company that has been developing its tires-to-oil technology since 2009 at a pilot plant in Warren, declined to identify the U.S. investor or the potential site or sites for the proposed plant. The agreement provides funding of up to $100 million for the roll out of additional plants in the U.S., if the first project is successful, the company claims. 

Commenting on the deal, GDT Chief Operating Officer Trevor Bayley said the agreement was achieved through a considerable amount of negotiation. "In the light of this burgeoning environmental disposal problem, our approach provides a recycling solution as we turn a problem into valuable and saleable materials," Bayley said, noting that there are more than 250 million end-of-life tires generated in the U.S. annually.

Green Distillation has developed what it claims is an emissions-free technology that is capable of recycling whole end-of-life car and truck tires into saleable commodities of carbon, oil and steel. The company claims that the oil produced through its technology is comparable with "light crude, which is low in sulphur and easy to refine into petrol, diesel, jet fuel and other petroleum-based products." GDC also maintains that the carbon produced in the process is a high-grade product with high potential for sale as carbon black. 

The deal marks GDT's second overseas venture, following an agreement in October last year with waste-to-power specialist Volco Power to establish up to five tire recycling plants in South Africa. That deal could potentially be worth up to AUD$50 million, according to the company. GDT states an ideal plant complex would comprise six tire processing modules capable of processing approximately 700,000 old tires per year into 8 million liters of oil, 7,700 metic tons of carbon black and 2,000 tons of steel.

In addition to its pilot plant in Warren, GDT is working on a second plant to be built in Toowoomba, Australia. 

GDT Signs US Deal


GDTC SIGNS AN AGREEMENT WITH SPARATECH CEO CO-FOUNDER JOHN LYONS

Agreement


Georgia Pacific signs evaluation agreement with ATI based on test results will sign a license agreement

The ATI-Composite fire door core will provide superior performance as it relates to the density of the core, the weight of the core or the styles and rails and the thermal resistance of the ATI core when compared to the current GP core material under fire conditions. Also API is effective for wall and floor panels as 80 % less weight and better performance ( fire protection )

product sample evaluation agreement


JLM client Dualis brings in ReliantHeart

Dualis MedTech and ReliantHeart Partner on Fully Implantable TET System for the HeartAssist5® LVAD

ReliantHeart, Inc., an innovative supplier of advanced mechanical circulatory assist technologies, and Dualis MedTech GmbH, a provider of wireless energy and charging technology, have joined together to implement a wireless, Transcutaneous Energy Transfer system (TET) exclusively for the HeartAssist5® Ventricular Assist Device.

Dualis has agreed to integrate its wireless energy transfer technology MedBase® with the HeartAssist5® VAD.  ReliantHeart’s novel HeartAssist5® (HA5) is the most energy efficient LVAD available.

In its new configuration, the HA5 will draw less than half of the energy of any other full flow LVAD. ReliantHeart refers to this energy efficient pump as being Forward Compatible with future product introduction, including the wireless Transcutaneous Energy Transfer system (TET).

Dualis is an integral part of a Forward Compatibility team formed by ReliantHeart to cooperate on an assembly of technologies intended to reduce adverse events associated with LVADs.  The team includes several other companies: Lynium, Kollmorgen, Device Solutions, Transonic, Revel Engineering, Numerex, Cathtek, and Yarborough Electronics.

Several months of collaboration culminated in Houston last month, where engineers and product managers from these companies shared a behind-the-scenes tour of the Johnson Space Center, an appropriate setting for both Dualis and ReliantHeart whose roots stem from the aerospace industry.   Dualis was formed from the German Centre for Aeronautics and Aerospace, and now implements its technologies for the medical device industry.  ReliantHeart’s ventricular pump was developed with NASA technology and was awarded the NASA Invention of the Year.

According to ReliantHeart CEO Rodger Ford; “Dualis is heads and shoulders above most similar teams of its kind.  Our partnership is more than just collaboration, it is a crusade to reduce adverse events in the LVAD field. Our mission is to compress time and accelerate beneficial outcomes.  Artificial heart pumps need power but running wires through the skin leads to infection and patient discomfort.  The solution is to invent a device to transfer power without wires.”

Dualis MedBase® technology will provide this solution by using magnetic coils to transfer power from outside to inside the body with no wires that penetrate the body.  It sounds like science fiction, and yet will be available in 2016. Patients with a ReliantHeart HA5 will be able to upgrade to the wireless system without exchanging the pump, thereby eliminating driveline infection.  “Patients will be able to enjoy the physical and social activities that are limitless without a wire,” Ford said.

Dualis MedTech GmbH started research and development of the MedBase® technology in 2006 and has since gained a substantial lead in wireless power technology, and conducted successful animal trials. Stephan Sagolla, CEO of Dualis indicated, “The internal coil is about two inches in diameter and will communicate with an internal battery and power management much like a pacemaker system. The patient will be wireless.”

ReliantHeart, Inc. is an innovative supplier of advanced mechanical circulatory assist technologies that are changing the approach to the treatment of advanced heart failure.  It develops and manufactures the HeartAssist5® Ventricular Assist Device.  ReliantHeart’s roots are in Houston, Texas, where it has been generously influenced by the transplant centers of Texas Heart, Methodist DeBakey and Memorial Hermann, and its technology originally inspired by NASA, the Johnson Space Center and Baylor School of Medicine.

Dualis MedTech GmbH is an innovative development service provider which supports its customers from the idea stage right through to the certification of tailor-made systems and products. As a spin-off of the Deutsches Zentrum für Luft- und Raumfahrt (DLR e. V., German Centre for Aeronautics and Aerospace), the company has transferred technology used in aeronautics and applied it to medical technology and also provide services to other sectors such as the automotive supply industry, consumer electronics and machine and plant construction.

Dualis offers manufacturers of medical devices and active implants a fully comprehensive service package for the production, integration and adjustment of MedBase® to their proprietary products. Dualis complies with the extremely demanding regulatory requirements for medical devices.


 

Agency aims to help startups tap the U.S. market

EE Times News and Analysis • Colin Holland

LONDON — A company is looking for European electronics startups that want to exploit the world-wide market will be organizing a series of launch events at CES 2009 in Las Vegas in January for executives wishing to meet with key decision makers at Fortune 500 companies. 

Some companies say they have already successfully gone down this route using J Lyons Marketing (JLM) including Powercast (Pittsburgh) which won the CES emerging new technology for 2007 award. “We were just coming out of stealth mode and, with JLM connections, we exploded at CES,” said John Shearer, co-founder of Powercast. In 2008, JLM brought senior directors from 22 companies around the world together to meet and do business. “It was an incredibly cost effective way for us to meet with the right people and get the feedback needed to finish final development,” added Shearer. 

“Our company was boosted with immediate value and credibility. It is a great service and beats the alternative of travelling round booths hoping to find someone who might be interested in us,” added Tolga Katas, Founder and Director of en2go International Inc. a California-based company, that looks beyond web 2.0 in the creation of digital entertainment and technology intelligence and added Steve Wozniak to its board of directors earlier this year. 

Getting started in the huge American market can be a daunting challenge for European technology companies, especially start ups. St Davids, Pennsylvania-based J Lyons Marketing (JLM) has over twenty years of experience of introducing European companies to the decision makers at prospective Fortune 500 customer organisations with over a billion dollars of design win successes into products ranging from cell phones to automatic utility meter readers. “We know the CTOs of major American technology companies on first name terms,” explained John Lyons, President and Founder of JLM. “By keeping in regular contact we know exactly what technology challenges they are facing both now and in the future. This means that when we call them with a possible solution from one of our clients, they listen because we have track record of delivering exactly what they need for years and years.” 

“It is a matchmaking process based on intimate understanding of both technology needs and technology solutions. It would be very hard for European company to cold call and hope to find decision maker who happened to have a problem that their technology could solve,” added Lyons. 

Most of the clients that JLM represents are European because, as Lyons explained, Europe has a tremendous pool of engineers creating innovative technologies and products but they lack the contacts to crack the lucrative American market. 

Peratech, the leader in new materials designed for touch technology solutions, is one of the clients that JLM has recently started working with. Martin Kingdon, Peratech’s Sales Manager, said, “JLM gets doors open at a senior level with customers and gets to the right people very quickly.” Another success story for JLM was with Maxell, and saw its Lithium Thionyl chloride batteries used in utility meters and in set top boxes while its lithium-ion prismatic cells have enjoyed huge success with cell phone manufacturers. “JLM has helped us become one of the world’s leading manufacturers of speciality batteries,” said Bob Meadows, National Sales Manager at Maxell.


the matchmaker

Bolaji Ojo, Editor in Chief, EBN, The Premier Online Community for Global Supply Chain Profeessionals

 

The electronics industry likes to celebrate success, touting the unusual circumstances under which many of its biggest companies were founded -- the garage is a favorite location.

It often fails to mention the hundreds, possibly thousands of other technological innovations that died unsung because the entrepreneurs either couldn't get anyone to pay attention to their ideas or failed to secure critical funding.

The stories many of us will ever get to know about events in the technology world are those of the successful companies, enterprises like Amazon, Apple, Facebook, Google, Hewlett-Packard, and Yahoo. But many others never get to Wall Street because their products failed to make it to Main Street. So, how can startups and innovators give their ideas and products the opportunity to get included in the narratives of successful companies?

The hurdles are certainly numerous. Many technological innovations die on the vine due to a variety of factors, the top reasons being lack of funding, failure to attract the right type or any sort of viable partnerships, insufficient marketing, management missteps resulting from inexperience, insurmountable competitive opposition, poor product timing, supply chain challenges such as inability to attract the patronage of suppliers, contract manufacturers and other third-party support services providers, and simply poor design of a potentially great product.

In the electronics industry, one of the toughest obstacles to the success of a new product -- in the case of components -- is failure to find a home for the parts in existing products. The industry jargon for this is "design win," which refers to the possibility of getting the component included in the list of components used by the engineer when designing the end-equipment.

A "win" on a major OEM's platform, printed-circuit board, software, or enclosure is a highly coveted victory for a startup. Scoring a "design-win," for example, on products from Apple Inc. (Nasdaq: AAPL), could translate literally into tens of millions in sales for a startup and give its products greater visibility with other manufacturers.

But how can a startup in southern France, central UK, or the Midwest of the United States score such a win? How can an innovative enterprise even get its products before the top procurement and supply chain executives at companies that control tens of billions in purchasing expenses per year? What will it take for Apple to review a component vendor's latest innovation when the manufacturer does not have a history of supplying components to the world's biggest consumer electronics company and has no direct links with its supply chain boss?

That's where folks like John Lyons come in. A veteran of the electronics industry, Lyons is CEO of J Lyons Marketing, a technology matchmaking firm that assists developers in bridging the wide gulf separating them from the companies that can benefit from and help market their products.

Lyons told me in an interview that his company's specialty is hooking developers up with Fortune 500 enterprises. "If the technology can do what the manufacturer wants, we'll help you find a home for it," Lyons said. It's not quite that simple, though. The first step to scoring that design win is convincing technology matchmakers like Lyons that the innovation is worth hawking around. Matchmakers are valued by OEMs especially because they would have already done much of the vetting that the enterprise would have to do if the middleman wasn't involved. Lyons said in a statement he emailed to me:

Over the years, we have been responsible for matchmaking hundreds of technology deals worth over a billion dollars. On one hand, we keep in constant contact with the CTOs of Fortune 500 companies so that we know the problems that they are trying to solve. It would be extremely hard for companies in Europe to know exactly which person in any number of vast US companies might be interested in their new technology but we do. Not only that but these guys will take our call because they know we deliver solutions time after time.

The products introduced to equipment manufacturers for consideration by technology marketers like Lyon must have already passed muster with the middleman who require have a deep knowledge of the customer's products and may even be aware of its product roadmap. In order to sustain the relationship on both sides, Lyons and his team are constantly in touch with CTOs at equipment vendors and spend a great deal of time hunting for valuable innovations.

An introduction by Lyons to a Fortune 500 company is not a guarantee of success, though. He admits to scoring wins regularly but added that many of the innovations he considers may not get past the front door at the equipment vendor. Lyons counts amongst "his successes a camera chip design win of 50 million units and counting, a battery design win for a Set Top Box worth $400 million, and a new disposable sample gathering device used in diagnostic testing with the potential to sell millions of units a year."

Of course, if matchmakers like Lyons cannot deliver the goods, there are other avenues technology innovators and startups can pursue. They can leverage the strength of funding partners, tap the vast knowledge and contacts available at distributors, and if all else fails, there's always the chance cold calling the OEMs might elicit some interest. It's a long shot but it may just be worth trying -- after all, both parties are always on the lookout for something different, something that improves their competitiveness.

 

 

NEWS RELEASE 

Technology Matchmaker, J Lyons Marketing, hired as Technology Scout
by Fortune 500 company to bring European innovation to the US

 

Wayne, Pennsylvania – J Lyons Marketing (JLM) has been hired as a Technology Scout by a Fortune 500 company and will be responsible for sourcing innovative technologies from Europe. JLM has over 25 years’ experience in working with European high technology companies as a Technology Representative in the US. 

“We have been working with this Fortune 500 company for a number of years,” explained John Lyons, CEO of J Lyons Marketing, “bringing new technologies to them from clients that I represent. Being hired as a Technology Scout, is a first for us and reverses the whole process. We will be working closely with the CTO and the company road maps to determine exactly what new technologies will be needed to enable the company to execute on its product strategies. Having worked with dozens of European companies and start-ups over the years and numerous research institutes, we know where to go looking for solutions that are game changers that could enable billion dollar sales. They are currently a $19 billion company and they want to double in size within a few years through innovation and acquisitions – they are buying European companies at the rate of ten a year and want us to help find the right ones to buy be they start ups or well established companies.” 

According to the Global Innovation Index 2012, seven of the top countries for innovation are European and the USA is in tenth place. “Europe is an amazing source of innovation,” added John Lyons, “and the US is number one for acquiring new technologies. Key sources of innovation are the universities doing blue sky research that then spin out companies to commercialise the new technologies. This non-VC based model is working well in today’s financially challenged times and is enabling Europe to be an innovative powerhouse. Our close connection with the incubator facilities at universities ensures that we know what new technologies are coming down the pipe at a really early stage so we can match-make them to the technology requirements of US companies, who can often provide financial support and advice as the lead customer to speed the development.” 

John Lyons concluded, “A company’s road map is its crown jewels. By being an external Technology Scout, we can provide our client with anonymity during the search process so that rivals don’t know who is looking for what, preserving the secrecy of or client’s road map strategy.” 

J Lyons Marketing focusses on high technology in the areas of Consumer Electronics, Life Sciences, medical devices, drug delivery systems, diagnostics, energy, building automation, and clean technology. 

Further information can be found at www.jlyonsmarketing.com